title: Early neoplastic progression is complement independent.
abstract: Infiltration of leukocytes into premalignant tissue is a common feature of many epithelial neoplasms and is thought to contribute to cancer development. However, the molecular and cellular regulatory mechanisms underlying activation of innate host responses to enhanced neoplastic cell proliferation are largely unknown. Considering the importance of the complement system in regulating inflammation during acute pathologic tissue remodeling, we examined the functional significance of complement component 3 (C3) as a regulator of inflammatory cell infiltration and activation during malignant progression by using a transgenic mouse model of multistage epithelial carcinogenesis, e.g., HPV16 mice. Whereas abundant deposition of C3 is a characteristic feature of premalignant hyperplasias and dysplasias coincident with leukocyte infiltration in neoplastic tissue, genetic elimination of C3 neither affects inflammatory cell recruitment toward neoplastic skin nor impacts responding pathways downstream of inflammatory cell activation, e.g., keratinocyte hyperproliferation or angiogenesis. Taken together, these data suggest that complement-independent pathways are critical for leukocyte recruitment into neoplastic tissue and leukocyte-mediated potentiation of tumorigenesis.
authors.affiliation: Cancer Research Institute, University of California, San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA.
authors.forename: Karin E
authors.initials: KE
authors.lastname: de Visser
authors.forename: Lidiya V
authors.initials: LV
authors.lastname: Korets
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Coussens
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic; D003176:Complement C3 / Q000378:metabolism*; D005434:Flow Cytometry; D007074:Immunoglobulin G / Q000276:immunology; D007150:Immunohistochemistry; D015603:Keratinocytes / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009389:Neovascularization, Pathologic / Q000473:pathology; D012878:Skin Neoplasms / Q000276:immunology* / Q000473:pathology*
chemical_list: D003176:Complement C3; D007074:Immunoglobulin G
references.citation: J Immunol. 2003 Dec 1;171(11):6225-35
references.pmid: 14634139
references.citation: J Exp Med. 1998 Sep 21;188(6):1135-45
references.pmid: 9743532
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1213-7
references.pmid: 11700271
references.citation: Epidemiology. 2001 Jan;12(1):88-93
references.pmid: 11138826
references.citation: BMC Cancer. 2003 Oct 31;3:28
references.pmid: 14588079
references.citation: J Immunol. 2003 Feb 15;170(4):1630-4
references.pmid: 12574324
references.citation: Blood. 1997 Apr 15;89(8):2863-70
references.pmid: 9108406
references.citation: Br J Cancer. 2001 Apr 6;84(7):965-8
references.pmid: 11286478
references.citation: J Exp Med. 2003 Apr 21;197(8):1017-28
references.pmid: 12695493
references.citation: Oncology (Williston Park). 2002 Feb;16(2):217-26, 229; discussion 230-2
references.pmid: 11866137
references.citation: Proc Natl Acad Sci U S A. 1990 Apr;87(8):3230-4
references.pmid: 2326280
references.citation: J Immunol. 1999 Jan 15;162(2):1127-36
references.pmid: 9916743
references.citation: J Natl Cancer Inst. 1999 Sep 1;91(17):1459-67
references.pmid: 10469746
references.citation: J Immunol. 1996 Aug 15;157(4):1693-8
references.pmid: 8759757
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: J Virol. 1994 Jul;68(7):4358-68
references.pmid: 7515971
references.citation: J Dermatol. 2000 Mar;27(3):157-62
references.pmid: 10774140
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: Am J Pathol. 1996 Dec;149(6):1899-917
references.pmid: 8952526
references.citation: J Immunol. 2002 Oct 1;169(7):3987-92
references.pmid: 12244200
references.citation: Am J Ther. 1995 Oct;2(10):761-767
references.pmid: 11854783
references.citation: Blood. 1990 Aug 15;76(4):655-63
references.pmid: 2200535
references.citation: Digestion. 2001;63 Suppl 1:103-7
references.pmid: 11173919
references.citation: Mol Biol Cell. 1998 Apr;9(4):875-84
references.pmid: 9529385
references.citation: J Immunol. 1999 May 1;162(9):5528-35
references.pmid: 10228034
references.citation: N Engl J Med. 2001 Apr 5;344(14):1058-66
references.pmid: 11287977
references.citation: Gastroenterology. 1990 May;98(5 Pt 1):1264-71
references.pmid: 1691118
references.citation: Cancer Res. 2004 Feb 1;64(3):952-61
references.pmid: 14871825
references.citation: Immunity. 1996 Oct;5(4):387-90
references.pmid: 8885871
references.citation: Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):128-32
references.pmid: 8278352
references.citation: Gut. 1997 Feb;40(2):196-203
references.pmid: 9071931
references.citation: Clin Exp Immunol. 1998 Mar;111(3):484-90
references.pmid: 9528887
references.citation: Immunology. 1975 Jun;28(6):1067-80
references.pmid: 48505
references.citation: Nat Rev Cancer. 2001 Oct;1(1):46-54
references.pmid: 11900251
references.citation: Genes Dev. 1999 Jun 1;13(11):1382-97
references.pmid: 10364156
references.citation: Am J Respir Cell Mol Biol. 2002 Oct;27(4):413-8
references.pmid: 12356574
references.citation: Oncogene. 1999 Dec 20;18(55):7908-16
references.pmid: 10630643
references.citation: J Immunol. 2001 Oct 15;167(8):4141-5
references.pmid: 11591733
references.citation: J Clin Invest. 1993 Nov;92(5):2480-8
references.pmid: 7693763
references.citation: J Immunol. 2000 Nov 15;165(10):5401-5
references.pmid: 11067890
references.citation: Immunol Rev. 2001 Apr;180:35-48
references.pmid: 11414361
references.citation: N Engl J Med. 2001 Apr 12;344(15):1140-4
references.pmid: 11297706
references.citation: Differentiation. 2002 Dec;70(9-10):610-23
references.pmid: 12492502
references.citation: Nature. 1997 Nov 13;390(6656):172-5
references.pmid: 9367154
references.citation: Eur J Immunol. 2001 Nov;31(11):3298-307
references.pmid: 11745347
references.citation: Cell. 2000 Oct 27;103(3):481-90
references.pmid: 11081634
references.citation: Immunity. 1995 Jul;3(1):21-6
references.pmid: 7621075
references.citation: Br J Dermatol. 1998 Nov;139(5):851-4
references.pmid: 9892953
references.citation: Pharmacotherapy. 2002 Mar;22(3):303-9
references.pmid: 11898889
references.citation: J Clin Invest. 1995 Apr;95(4):1539-44
references.pmid: 7706459
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11490-4
references.pmid: 8524789
references.citation: Br J Cancer. 2000 Jul;83(1):112-20
references.pmid: 10883678
references.citation: Annu Rev Microbiol. 2000;54:615-40
references.pmid: 11018139
references.citation: Science. 1994 Aug 19;265(5175):1095-8
references.pmid: 8066448
references.citation: Nat Rev Immunol. 2002 Oct;2(10):773-86
references.pmid: 12360215